Net profit of Syncom Formulations (India) rose 49.41% to Rs 16.60 crore in the quarter ended September 2025 as against Rs 11.11 crore during the previous quarter ended September 2024. Sales rose 18.97% to Rs 121.72 crore in the quarter ended September 2025 as against Rs 102.31 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales121.72102.31 19 OPM %15.1211.89 - PBDT23.3916.15 45 PBT22.0414.85 48 NP16.6011.11 49 Powered by Capital Market - Live News

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live News

Syncom Formulations (India) announced that the Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live News

Net profit of Syncom Formulations (India) rose 106.42% to Rs 15.75 crore in the quarter ended June 2025 as against Rs 7.63 crore during the previous quarter ended June 2024. Sales rose 33.97% to Rs 116.90 crore in the quarter ended June 2025 as against Rs 87.26 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales116.9087.26 34 OPM %13.5211.98 - PBDT21.5911.40 89 PBT20.2510.10 100 NP15.757.63 106 Powered by Capital Market - Live News

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 8 August 2025.Powered by Capital Market - Live News